Thomas J. Herzfeld Advisors Inc. Invests $111,000 in UnitedHealth Group Inc (UNH)

Thomas J. Herzfeld Advisors Inc. acquired a new position in UnitedHealth Group Inc (NYSE:UNH) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 694 shares of the healthcare conglomerate’s stock, valued at approximately $111,000.

A number of other large investors have also made changes to their positions in the company. First Personal Financial Services boosted its stake in UnitedHealth Group by 36.9% in the third quarter. First Personal Financial Services now owns 742 shares of the healthcare conglomerate’s stock worth $104,000 after buying an additional 200 shares during the last quarter. Itau Unibanco Holding S.A. bought a new position in shares of UnitedHealth Group during the third quarter worth $111,000. Intellectus Partners LLC bought a new position in shares of UnitedHealth Group during the fourth quarter worth $111,000. Elite Wealth Management LLC bought a new position in shares of UnitedHealth Group during the third quarter worth $114,000. Finally, Adirondack Trust Co. increased its position in shares of UnitedHealth Group by 16.4% in the third quarter. Adirondack Trust Co. now owns 885 shares of the healthcare conglomerate’s stock worth $124,000 after buying an additional 125 shares during the period. Institutional investors and hedge funds own 86.67% of the company’s stock.

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

UnitedHealth Group Inc (NYSE:UNH) traded down 0.020% during trading on Friday, reaching $171.505. 1,964,570 shares of the company traded hands. UnitedHealth Group Inc has a 52 week low of $128.53 and a 52 week high of $172.62. The company has a market capitalization of $163.13 billion, a P/E ratio of 23.656 and a beta of 0.68. The firm has a 50-day moving average price of $167.19 and a 200-day moving average price of $157.47.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, April 18th. The healthcare conglomerate reported $2.37 EPS for the quarter, beating the consensus estimate of $2.17 by $0.20. The company earned $48.72 billion during the quarter, compared to analysts’ expectations of $48.21 billion. UnitedHealth Group had a return on equity of 21.20% and a net margin of 3.92%. The firm’s revenue was up 9.4% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.81 EPS. Analysts forecast that UnitedHealth Group Inc will post $9.51 earnings per share for the current fiscal year.

TRADEMARK VIOLATION NOTICE: This news story was originally posted by Chaffey Breeze and is owned by of Chaffey Breeze. If you are viewing this news story on another website, it was illegally copied and republished in violation of US & international trademark & copyright laws. The correct version of this news story can be accessed at https://www.chaffeybreeze.com/2017/04/21/thomas-j-herzfeld-advisors-inc-takes-position-in-unitedhealth-group-inc-unh-updated.html.

UNH has been the topic of a number of research analyst reports. Argus restated a “buy” rating and set a $170.00 price objective on shares of UnitedHealth Group in a research report on Monday, January 23rd. Jefferies Group LLC restated a “buy” rating and set a $186.00 price objective on shares of UnitedHealth Group in a research report on Tuesday, January 10th. Barclays PLC restated a “buy” rating and set a $187.00 price objective on shares of UnitedHealth Group in a research report on Monday, January 9th. Zacks Investment Research upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $177.00 price objective on the stock in a research report on Wednesday, February 22nd. Finally, Vetr downgraded shares of UnitedHealth Group from a “strong-buy” rating to a “buy” rating in a research report on Friday, February 10th. One investment analyst has rated the stock with a hold rating and twenty-three have issued a buy rating to the company. The stock currently has a consensus rating of “Buy” and an average target price of $181.05.

In other news, Director William C. Ballard, Jr. sold 5,000 shares of the business’s stock in a transaction dated Tuesday, February 14th. The stock was sold at an average price of $162.68, for a total transaction of $813,400.00. Following the completion of the sale, the director now owns 75,391 shares in the company, valued at approximately $12,264,607.88. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Richard T. Burke sold 10,000 shares of the business’s stock in a transaction dated Tuesday, January 31st. The stock was sold at an average price of $161.68, for a total value of $1,616,800.00. Following the sale, the director now owns 1,921,191 shares of the company’s stock, valued at approximately $310,618,160.88. The disclosure for this sale can be found here. Insiders have sold a total of 35,310 shares of company stock valued at $5,855,416 in the last quarter. Company insiders own 1.65% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

5 Day Chart for NYSE:UNH

Receive News & Ratings for UnitedHealth Group Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply